Increased Serum Soluble OX40 in Patients with Systemic Sclerosis
Kazuhiro Komura(Kanazawa University), Shinichi Sato(University of Tokyo Hospital), Ayumi Yoshizaki(University of Tokyo Hospital), Toru Yukami(Kanazawa University), Kazuhiro Shimizu(Toho University), Minoru Hasegawa(University of Fukui), Yohei Iwata(Fujita Health University), Masanari Kodera(Chukyo Hospital), Kazuhiko Takehara(Kanazawa University), Takamasa Wayaku(Kanazawa University), Manabu Fujimoto(Osaka Gakuin University), Fumihide Ogawa(Nagasaki University), Maki Murata(Kanazawa University)
Cited by 87
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438